Home / APIs / Mianserin hydrochloride Mianserin hydrochloride Main Therapeutic Application: Antidepressant CAS-RN: 21535-47-7 CONTACT US More information Mianserin hydrochloride (CAS-RN 21535-47-7) is an atypical antidepressant (tetracyclic antidepressant (TeCA))used for the treatment of major depressive disorder (higher doses) or insomnia (lower doses). Mianserin hydrochloride is thought to work by interfering with certain brain chemicals (called neurotransmitters) which may be involved in causing the symptoms of depression. It can be especially helpful to patients who are also having difficulty sleeping. Product information Mianserin hydrochloride Main Therapeutic Application: Antidepressant CAS-RN: 21535-47-7 Specification: Ph. Eur Documentation: CEP* *Variation submited in March 2021 EDMF** **Available in September 2021 Related Products LEBSA, your partner in API’s Manufacturing in Barcelona (EU) US Your Partner in API’s Manufacturing Who we are Legal Notice Standard API’s API’s Pipeline Customer Support API R&D Contact Info 2021 LEBSA All rights reserved. Website Powered by tbbAgency By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Accept All Cookies

Home / APIs / Betahistine Dihydrochloride Betahistine Dihydrochloride Main Therapeutic Application: Antivertigo agent – agonist of histamine CAS-RN: 5579-84-0 CONTACT US More information Betahistine Dihydrochloride (CAS-RN 5579-84-0) is a histamine analogue. It is commonly used to treat Ménière’s syndrome, a condition that causes vertigo, tinnitus and hearing loss in people who suffer from this disease. The medication can also treat other balance disorders. The Betahistine Dihydrochloride improves blood flow in the inner ear, reducing pressure and hence treating the symptoms. Product information Betahistine Dihydrochloride Main Therapeutic Application: Antivertigo agent CAS-RN: 5579-84-0 Specification: Ph. Eur./USP Documentation: EDMF/CEP Related Products Betahistine Dimesilate Main Therapeutic Application: Antivertigo agent - agonist of histamine CAS-RN: 54856-23-4 More information LEBSA, your partner in API’s Manufacturing in Barcelona (EU) US Your Partner in API’s Manufacturing Who we are Legal Notice Standard API’s API’s Pipeline Customer Support API R&D Contact Info 2021 LEBSA All rights reserved. Website Powered by tbbAgency By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Accept All Cookies